[1]
Z. Butt and S. Shah, “Daclatasvir plus Sofosbuvir with or without ribavirin in patients with chronic Hepatitis C genotype 3a in Pakistani population - A real world experience”, PJMS, vol. 35, no. 2, Mar. 2019.